We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
476
Salesforce
CRM
$158B
$414K 0.03%
3,558
-29,084
-89% -$3.34M
PII icon
477
Polaris
PII
$4.07B
$414K 0.03%
+3,617
New +$435K
CPE
478
DELISTED
Callon Petroleum Company
CPE
$414K 0.03%
+3,130
New +$367K
ATRC icon
479
AtriCure
ATRC
$2.11B
$413K 0.03%
20,138
+1,086
+6% +$19.6K
NCNA
480
NuCana
NCNA
$6.12M
$408K 0.03%
+4
New +$380K
ENLC
481
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$407K 0.03%
+27,750
New +$467K
KHC icon
482
CALL
Kraft Heinz
KHC
$30B
$405K 0.03%
+6,500
New +$465K
NEOS
483
DELISTED
Neos Therapeutics, Inc
NEOS
$403K 0.03%
48,532
+2,811
+6% +$26.8K
CERS icon
484
Cerus
CERS
$474M
$402K 0.03%
+73,316
New +$333K
PLD icon
485
Prologis
PLD
$133B
$402K 0.03%
6,386
-3,458
-35% -$215K
HCA icon
486
HCA Healthcare
HCA
$89.5B
$401K 0.03%
+4,136
New +$401K
RVNC
487
DELISTED
Revance Therapeutics, Inc.
RVNC
$399K 0.03%
12,970
-4,012
-24% -$129K
REG icon
488
Regency Centers
REG
$14.1B
$396K 0.03%
6,710
+4,594
+217% +$278K
ADC icon
489
Agree Realty
ADC
$9.41B
$395K 0.03%
+8,212
New +$394K
AMJ
490
PUT
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$394K 0.03%
+16,400
New +$449K
WEX icon
491
WEX
WEX
$6.31B
$392K 0.03%
+2,500
New +$376K
ITCI
492
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$392K 0.03%
18,645
+17,470
+1,487% +$340K
EGN
493
DELISTED
Energen
EGN
$392K 0.03%
+6,240
New +$350K
CBOE icon
494
Cboe Global Markets
CBOE
$29.9B
$388K 0.03%
+3,398
New +$413K
ROKU icon
495
Roku
ROKU
$22.7B
$385K 0.03%
+12,380
New +$510K
BFX
496
DELISTED
BowFlex Inc.
BFX
$383K 0.03%
28,447
+19,201
+208% +$243K
AVEO
497
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$381K 0.03%
13,150
BEDU
498
DELISTED
Bright Scholar Education Holdings
BEDU
$380K 0.03%
+6,150
New +$470K
QDEL icon
499
QuidelOrtho
QDEL
$838M
$379K 0.03%
+7,308
New +$340K
GILD icon
500
Gilead Sciences
GILD
$165B
$378K 0.03%
5,012
-8,002
-61% -$636K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.